Analytical Data
-
基因名
WARS1
- Application
-
别名
(Interferon-induced protein 53)(IFP53)(Tryptophanyl-tRNA synthetase)(TrpRS)(hWRS)
-
种属
Human
-
表达系统
HEK293
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P23381
-
表达区间
2-471aa
-
分子量
56.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WARS1, or Tryptophanyl-tRNA Synthetase 1, is an essential enzyme involved in protein synthesis, specifically in the translation of genetic code into functional proteins by attaching the amino acid tryptophan to its corresponding tRNA molecule. Research into WARS1 has gained momentum due to its significant roles not only in ribosomal function but also in cellular stress responses and immune regulation. Abnormalities in WARS1 expression have been implicated in various diseases, including cancer and autoimmune disorders, making it a potential target for therapeutic intervention. Recent studies have focused on the structural and functional characterization of WARS1, particularly its enzymatic activity and interactions with other cellular components. Moreover, the development of recombinant WARS1 proteins has enabled researchers to explore its biochemical properties and investigate its role in disease pathology. Such recombinant proteins serve as valuable tools for elucidating the mechanistic pathways influenced by WARS1 and for drug discovery processes aimed at treating conditions linked to its dysfunction. Understanding the implications of WARS1 in cellular mechanisms is crucial for advancing knowledge in molecular biology and enhancing strategies for clinical applications.
